Serum Institute of India seeks emergency use nod for Covishield vaccine
New Delhi: Serum Institute of India (SII) has applied for emergency use authorization of the first Made in India Covid-19 ...
Read moreDetailsNew Delhi: Serum Institute of India (SII) has applied for emergency use authorization of the first Made in India Covid-19 ...
Read moreDetailsMoscow: Russia's Sputnik V vaccine against Covid-19 will cost governments much lower than that of Pizer's and Moderna's, the official ...
Read moreDetailsMumbai: The key Indian equity indices hit fresh record highs Tuesday tracking a positive global trend after pharma giant Moderna ...
Read moreDetailsNew Delhi: Union Health Minister Harsh Vardhan Thursday said that the coronavirus vaccine will be made available in the country by ...
Read moreDetailsNew York: Using a computer simulation model, scientists in the US have assessed the effectiveness and coverage levels a potential ...
Read moreDetailsNew Delhi: In its march towards developing a safe coronavirus vaccine India is sure leaving no stone unturned. The two ...
Read moreDetailsMoscow: Russia has reportedly produced the first batch of its new vaccine for Covid-19, Sputnik V, the Interfax news agency ...
Read moreDetailsBrussels: The European Union (EU) has reached its first agreement to purchase a potential vaccine against COVID-19 once it is ...
Read moreDetailsNew Delhi: The government Wednesday said a single central system will be set up to procure COVID-19 vaccines for vaccine ...
Read moreDetailsMoscow: Russia will start the production of its COVID-19 vaccine within two weeks, the country's health minister Mikhail Murashko said. ...
Read moreDetails